Site search

Refer a patient

Some of our services and clinics have a preferred form or process for referring clinicians to use when referring a patient. You can find specific referrals information on each of our service pages.

Chronic Kidney Disease RMH Service

We provide treatment, care and support for people diagnosed with chronic kidney disease.

Atezolizumab plus bevacizumab for treated hepatocellular patients at high risk of recurrence Research study

A clinical trial to assess the effectiveness of a combination immunotherapy versus active surveillance for treated hepatocellular patients who are at high risk of recurrence.

Abatacept combined with nasal insulin to preserve beta-cell function in recently diagnosed type 1 diabetes Research study

Preserving pancreas function can make glucose control easier and reduce the need to use injected insulin

Emergency Department RMH Service

We care for extremely unwell people from all parts of Victoria.

Phase I study of two second generation COVID-19 variant vaccines News article

The Doherty Institute, a joint venture between The University of Melbourne and the Royal Melbourne Hospital, has been funded through the National Health and Medical Research Council (NHMRC) by the Medical Research Future Fund to conduct a unique Phase I study of two second generation COVID-19...

Your medication

When you come to hospital, bring your medication with you, including non-prescription or complementary therapy medicines.

A/Prof Daniel Steinfort receives highest accolade in his field News article

Congratulations to Associate Professor Dan Steinfort being awarded the gold medal in clinical techniques, imaging and endoscopy from the European Respiratory Society (ERS) awards.

Antipsychotic dose reduction to improve recovery and function in young people with psychosis Research study

The REDUCE study is testing whether reducing the dosage of antipsychotic medication of people recovering from their first episode of psychosis can lead to them having better recovery outcomes.

Addressing the elephant in the room this R U OK Day News article

Today is R U OK Day, and today we’re addressing a very special elephant in the room.

New blood test to diagnose and monitor autoimmune blistering skin conditions Research study

A prospective study on serum antibodies against target antigens of bullous autoimmune diseases and genetic susceptibility.

A clinical trial testing a new investigational medication for people living with Graves’ Disease Research study

The purpose of this study is to compare a potential new treatment with improved side effects compared to current therapies in people living with Graves’ Disease. 

Amlitelimab (KY1005) for moderate to severe atopic dermatitis Research study

A clinical trial to assess a new drug called amlitelimab (KY1005) as a treatment for moderate to severe atopic dermatitis (eczema)

About Telehealth

Telehealth video calls connect you and your family with our specialists online, so you don't need to come to the hospital for your appointment.

Emergency Mental Health RMH Service

We provide specialist assessment, consultation, short-term care and referral for people experiencing a mental health crisis while in an Emergency Department.

Effects of denosumab on normal breast tissue for BRCA gene carriers Research study

A trial to investigate the effects of denosumab on normal breast tissue in patients with BRCA 1 or 2 mutations and to determine if the drug has the potential to prevent breast cancer.

See a private psychiatrist or psychologist

Psychiatrists and psychologists are mental health professionals who specialise in treating mental illness and difficulties with emotions, behaviour or lifestyle.

The Royal Melbourne Hospital employs record number of international recruits News article

Health Minister Mary-Anne Thomas visits the RMH

Requests under the Children, Youth and Families Act 2005

The Royal Melbourne Hospital is a prescribed Information Sharing Entity under the Children, Youth and Families Act 2005.

Treatment for moderately to severely active ulcerative colitis Research study

A clinical trial to assess whether guselkumab and golimumab when used together is safe and effective for treating participants with moderately to severely active ulcerative colitis (UC).